811 related articles for article (PubMed ID: 12297050)
1. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
Saxon ML; Lee DC
J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
[TBL] [Abstract][Full Text] [Related]
3. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.
Garrett TP; McKern NM; Lou M; Elleman TC; Adams TE; Lovrecz GO; Zhu HJ; Walker F; Frenkel MJ; Hoyne PA; Jorissen RN; Nice EC; Burgess AW; Ward CW
Cell; 2002 Sep; 110(6):763-73. PubMed ID: 12297049
[TBL] [Abstract][Full Text] [Related]
5. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
[TBL] [Abstract][Full Text] [Related]
6. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
Sanders JM; Wampole ME; Thakur ML; Wickstrom E
PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
[TBL] [Abstract][Full Text] [Related]
8. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for EGFR ligand sequestration by Argos.
Klein DE; Stayrook SE; Shi F; Narayan K; Lemmon MA
Nature; 2008 Jun; 453(7199):1271-5. PubMed ID: 18500331
[TBL] [Abstract][Full Text] [Related]
10. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope.
Santra M; Reed CC; Iozzo RV
J Biol Chem; 2002 Sep; 277(38):35671-81. PubMed ID: 12105206
[TBL] [Abstract][Full Text] [Related]
11. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
Moriai T; Kobrin MS; Hope C; Speck L; Korc M
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
[TBL] [Abstract][Full Text] [Related]
12. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
13. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence.
He L; Hristova K
Sci Rep; 2012; 2():854. PubMed ID: 23152945
[TBL] [Abstract][Full Text] [Related]
14. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor.
Lu C; Mi LZ; Schürpf T; Walz T; Springer TA
J Biol Chem; 2012 Nov; 287(45):38244-53. PubMed ID: 22988250
[TBL] [Abstract][Full Text] [Related]
16. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
Alvarado D; Klein DE; Lemmon MA
Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
[TBL] [Abstract][Full Text] [Related]
18. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.
Lu C; Mi LZ; Grey MJ; Zhu J; Graef E; Yokoyama S; Springer TA
Mol Cell Biol; 2010 Nov; 30(22):5432-43. PubMed ID: 20837704
[TBL] [Abstract][Full Text] [Related]
19. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
Taylor ES; Pol-Fachin L; Lins RD; Lower SK
Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
[TBL] [Abstract][Full Text] [Related]
20. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]